Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORBIT-IPF: ORJ-001 in Idiopathic Pulmonary Fibrosis
NCT07869147Phase 2Recruiting
- Start
- Oct 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
A Phase 2 trial of ORJ-001 in idiopathic pulmonary fibrosis (IPF). Started Oct 2026; status: recruiting.
02
Drugs
ORJ-001
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT07869147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869147.